Forxiga 5 mg, 10 mg FC tablets
PDF Leaflet Revision Date: 08 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
For type 2 diabetes mellitus, heart failure, and chronic kidney disease.
Dosage (summary)
10 mg once daily for adults; no adjustment for elderly or renal impairment.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Insulin
- Sulphonylureas
Contraindications
- Type 1 diabetes mellitus
- Hypersensitivity to dapagliflozin
- History of pancreatitis
Common side effects
- Genital infections
- Urinary tract infections
- Hypoglycaemia
Counselling Points
- Stay hydrated
- Report signs of ketoacidosis
- Monitor blood glucose regularly
Serious warnings
- Risk of ketoacidosis
- Monitor renal function
Important Disclaimer
The Forxiga 5 mg, 10 mg FC tablets professional information leaflet below is the property of Astrazeneca Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
